Skip to content

Supernumerary Der 22 T 8 22 Syndrome Cn074165

Published: July 22, 2026Updated: August 20, 2026

This chromosomal disorder involves extra genetic material from chromosome 22. It can cause developmental delays, distinctive facial features, and various health issues. Care is tailored to each individual's specific needs.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(congenital)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive cardiac evaluation

Detailed echocardiogram and electrocardiogram assessment to identify structural heart defects and conduction abnormalities associated with the supernumerary der(22) chromosomal abnormality.

monitoring
2

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Corrective cardiac surgery

Surgical repair of congenital heart defects such as tetralogy of Fallot or atrioventricular septal defects when present, following standard pediatric cardiac surgery protocols.

surgical

Additional treatment options

Cardiac arrhythmia management

Pharmacologic management of cardiac rhythm disturbances including beta-blockers or calcium channel blockers as appropriate for specific arrhythmia types identified in this syndrome.

medication

Activity restrictions and monitoring

Implementation of appropriate physical activity limitations based on cardiac status and regular monitoring for signs of exercise intolerance or arrhythmia symptoms.

lifestyle

Developmental and family support services

Comprehensive developmental assessment and family support including genetic counseling, educational support services, and referral to appropriate specialists for associated learning disabilities.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Supernumerary Der 22 T 8 22 Syndrome Cn074165?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Supernumerary Der 22 T 8 22 Syndrome Cn074165. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy